Thorne HealthTech

General Information

We are a science-driven wellness company pioneering innovative solutions and personalized approaches to health and well-being. We are building a new health category to deliver better health outcomes through a pro-active empowered approach. Our unique, vertically integrated brands, Thorne and Onegevity, provide actionable insights and personalized data, products and services that help individuals take a pro-active approach to improve and maintain their health over their lifetime. By combining our proprietary multi-omics database, artificial intelligence (AI) and digital health content with our science-backed nutritional supplements, we deliver a total system for wellness. We believe our integrated solution will redefine the expectations for good health and peak performance.

(Note: Thorne HealthTech priced its downsized IPO on Sept. 22, 2021, in line with the drastically reduced terms in its amended prospectus: 7 million shares at $10 – the bottom of its revised price range of $10 to $11 – to raise $70 million. Thorne HealthTech downsized its IPO in an S-1/A filing just hours ahead of pricing on Sept. 22, 2021: The deal was cut to 7 million shares, down from 9 million shares, and the price range was slashed to $10 to  $11, down from its initial price range of $13 to $15. The company now aims to raise $73.5 million, down from its initial projected proceeds of $126 million.)

Employees: 456
Founded: 1986
Contact Information
Address 152 W. 57th Street, New York, NY 10019. US
Phone Number (929) 251-6321
Web Address
View Prospectus: Thorne HealthTech
Financial Information
Market Cap $763.14mil
Revenues $162.3 mil (last 12 months)
Net Income $2.28 mil (last 12 months)
IPO Profile
Symbol THRN
Exchange NASDAQ
Shares (millions): 7.0
Price range $10.00 - $10.00
Est. $ Volume $70.0 mil
Manager / Joint Managers BofA Securities/ Cowen and Company/ Evercore
CO-Managers RBC Capital Markets
Expected To Trade: 9/23/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change